• E Cornu, I Belmihoub, N Burnichon, C Grataloup, F Zinzindohoué, S Baron, E Billaud, M Azizi, A-P Gimenez-Roqueplo, and L Amar.
• Unité d'hypertension artérielle, Centre de référence des maladies rares de la surrénale, université de Paris, hôpital européen Georges-Pompidou, AP-HP, 75015 Paris, France.
• Rev Med Interne. 2019 Nov 1; 40 (11): 733-741.

AbstractPhaeochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors that arise from the adrenal medulla or sympathetic and parasympathetic ganglia. These tumors produce most often catecholamines in excess, causing hypertension and sometimes severe acute cardiovascular complications. The diagnosis is based on plasma or urines metanephrines measurements and on conventional and nuclear medicine imaging. Catecholamines-producing PPGL is very unlikely if levels are normal. The diagnosis of PPGL cannot be made without visualization of a tumor. Therapeutic management consists mostly of surgical excision, after drug preparation, and should be done in referral centers. About 40% of pheochromocytomas and paragangliomas occur in the context of an autosomal inherited syndrome, making genetic testing essential. The follow-up must be prolonged because a metastatic evolution or a recurrence can be observed in about 15% of the cases.Copyright © 2019. Published by Elsevier Masson SAS.

34 keywords...

hide…